Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Epiomed Therapeutics Inc.

Drugs to tackle all forms of nausea and vomiting

This article was originally published in Start Up

Executive Summary

The various triggers that case nausea and vomiting are conveyed to the brain via different pathways that converge to create a final common pathway leading to the vomiting center in the medulla region of the brain. Previous attempts to develop drugs that target this common pathway have failed in the clinic because they produced anxiety and panic attacks, but Epiomed Therapeutics Inc. thinks it has discovered the reasons for the anxiety and is developing a redesigned product devoid of this side effect.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC092267

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel